BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Health Economics Association - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://healtheconomics.org
X-WR-CALDESC:Events for International Health Economics Association
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260606
DTEND;VALUE=DATE:20260612
DTSTAMP:20260609T053051
CREATED:20251116T003732Z
LAST-MODIFIED:20251116T005959Z
UID:334343-1780704000-1781222399@healtheconomics.org
SUMMARY:ASHEcon 2026 Annual Conference
DESCRIPTION:
URL:https://healtheconomics.org/event/ashecon-2026-annual-conference/
CATEGORIES:External Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260622T080000
DTEND;TZID=UTC:20260622T090000
DTSTAMP:20260609T053051
CREATED:20260604T170208Z
LAST-MODIFIED:20260608T150428Z
UID:335285-1782115200-1782118800@healtheconomics.org
SUMMARY:Preferences for care in advanced illness: new evidence from two studies in Asia
DESCRIPTION:📅 Add to Calendar!   |  🎥 Join Webinar on Zoom \nEvidence on preferences for care in advanced illness in Asia remains limited\, despite rapid ageing\, cultural diversity\, and constrained palliative care capacity. This session will feature two presentations that explore patient and family priorities\, with a view to informing person‑centered care and economic evaluation in this field. \nProf Eric Finkelstein (Duke-Singapore) will present on QCPAI (Quality of Care for Patients with Advanced Illness) – A Preference-Based Instrument to measure quality of care for patients with advanced illness in Asia Pac. [10.1016/j.vhri.2026.101620; 10.1016/j.jval.2025.05.006]. \nDr Tara Devi Laabar (University of Western Australia) will present on a discrete choice experiment on Bhutanese patients and family members to explore preferences for palliative care [10.1177/26323524251334183]. \nSpeakers: \n \nProfessor Eric Finkelstein\, PhD\, MHA  \nDr. Finkelstein is Professor of Economics at the Duke-NUS Medical School\, Singapore and the Executive Director of the Lien Centre for Palliative Care. His research focuses on the economic causes and consequences of health behaviors. A major focus are studies to better understand the complicated decisions that revolve around end-of-life care. He has published over 300 manuscripts and 2 books in these areas. Based on google scholar\, he has an h-index of 83 and his publications have been cited over 125\,000 times\, including in the landmark Supreme Court decision upholding the U.S. Affordable Care Act (aka Obamacare). He was included in the list of the World’s Most Highly Cited Researchers in 2015\, 2016 and 2017 by Thomson Reuters and Clarivate Analytics and among the Top 2% of scientists worldwide in a study by Stanford University in 2021 and 2025. \nTara Dev Laabar PhD\, MPH\, BN\, Dip GM   \nTara was a nurse educator in Bhutan. In 2015\, Tara was introduced to palliative care\, a field that was then relatively new in Bhutan. Her growing interest led her to undertake a six-week hands-on training program in palliative care at Pallium India\, Kerala\, in 2016. This experience inspired her to dedicate her career to the study\, practice\, and teaching of palliative care. \nIn 2018\, Tara moved to Australia to pursue a PhD in Palliative Care at the University of Western Australia. Her PhD research focused on developing a socially\, culturally\, and spiritually appropriate model of palliative care for Bhutan. On completion of her studies\, she returned to Bhutan\, where she contributed to palliative care advocacy\, education\, and capacity building. \nIn 2024\, due to family commitments\, Tara relocated to Perth\, Australia\, where she currently works as a Registered Nurse in residential aged care. She remains actively engaged in palliative care education\, particularly through virtual training and mentorship initiatives for healthcare professionals in LMICs. \nTara has authored and co-authored around 15 peer-reviewed publications and continues to promote equitable access to palliative care through research\, education\, and international collaboration.
URL:https://healtheconomics.org/event/preferences-for-care-in-advanced-illness-new-evidence-from-two-studies-in-asia/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260623T150000
DTEND;TZID=UTC:20260623T160000
DTSTAMP:20260609T053051
CREATED:20260602T154250Z
LAST-MODIFIED:20260602T154250Z
UID:335271-1782226800-1782230400@healtheconomics.org
SUMMARY:Health Economics Education and Application in India: Gaps and Opportunities
DESCRIPTION:📅 Add to Calendar!   |  🎥 Join Webinar on Zoom \nSpeaker: \nAndria J. N. Sirur is an Assistant Professor in Health Economics at the Manipal School of Commerce and Economics\, Manipal Academy of Higher Education (An Institute of Eminence)\, Manipal\, India. Her work focuses on health systems\, economic evaluation\, healthcare policy\, and evidence-based research to support informed decision-making in public health and healthcare management. Passionate about academic excellence and interdisciplinary collaboration\, she is committed to advancing research\, teaching\, and innovation in the field of health economics. \nJoin Dr Andrai J. N. Sirur for a discussion on Health Economics Education and Application in India: Gaps and Opportunities. Despite the growing recognition of its importance\, health economics in India remains underdeveloped. Specialised training in health economics\, health systems\, and financing is scarce\, with limited undergraduate instruction and only a few graduate or certificate programmes available. Whilst there has been an acknowledgement of the pertinence of health economics within public health curricula\, there is a paucity of uniformity with regard to the depth and consistency of the relevant courses offered by different institutions. Interdisciplinary collaboration with health institutes is weak\, and international research partnerships rarely translate into stronger domestic teaching capacity. The number of professionals trained in Health Technology Assessment (HTA) – a critical component of evaluating the cost-effectiveness of medical treatments – remains limited\, with a significant proportion of research output contingent on international collaboration. A further significant challenge pertains to the absence of comprehensive health system datasets. In the absence of standardised cost data\, economic evaluation\, and evidence-based priority setting are impeded\, which in turn complicates policy decisions. The development of high-quality curricula is further hindered by shortages of qualified teaching faculty and uneven institutional capacity. Collectively\, these structural barriers impede India’s capacity to institutionalise health economics within academic training and health system governance.
URL:https://healtheconomics.org/event/health-economics-education-and-application-in-india-gaps-and-opportunities/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260629T120000
DTEND;TZID=UTC:20260629T133000
DTSTAMP:20260609T053051
CREATED:20260506T164018Z
LAST-MODIFIED:20260526T182842Z
UID:335106-1782734400-1782739800@healtheconomics.org
SUMMARY:Development Assistance for Health at a Crossroads: Navigating Aid Cuts\, Fragility\, and Financing Trade-offs for Universal Health Coverage
DESCRIPTION:📅 Add to Calendar! |   🎥 Join Webinar on Zoom \nGlobal health financing is at a turning point. With DAH projected to decline by at least 20% from 2025\, low-income and fragile states face acute risks to essential health services — from HIV and maternal health to supply chains and health information systems. \nJoin us for a webinar bringing together researchers and practitioners to explore the evidence: What do we know about the impact of DAH on health outcomes? What can country experiences like Nigeria tell us about navigating these shifts? And what financing trade-offs must be made to keep UHC within reach? \nThe Webinar will be moderated by Peter Binyaruka (Ifakara Health Institute) and will be featuring presentations by Newton Chagoma (University of Birmingham)\, Jacopo Gabani (World Bank)\, Felix Obi (Results for Development\, Nigeria)\, Sakshi Mohan (University of York)\, and Sophie Witter (Queen Margaret University\, Edinburgh). \nSpeakers \nPeter Binyaruka – Health Economist\, Ifakara Health Institute \n  \n  \n  \nNewton Chagoma – Research Fellow\, University of Birmingham \n  \n  \n  \nJacopo Gabani – World Bank\, Health Economist \n  \n  \n  \nFelix Obi – Country Director for Nigeria & Senior Program Director\, Global Health Practice\, Results for Development (R4D) \n  \n  \n  \nSakshi Mohan – Research Fellow\, Centre for Health Economics (CHE)\, University of York \n  \n  \n\nSophie Witter – Professor of International Health Financing and Health Systems\, Queen Margaret University\, Edinburgh \n 
URL:https://healtheconomics.org/event/development-assistance-for-health-at-a-crossroads-navigating-aid-cuts-fragility-and-financing-trade-offs-for-universal-health-coverage/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260716T080000
DTEND;TZID=UTC:20260716T090000
DTSTAMP:20260609T053051
CREATED:20260601T161817Z
LAST-MODIFIED:20260601T161817Z
UID:335267-1784188800-1784192400@healtheconomics.org
SUMMARY:Designing for Decisions: Practical Strategies to Improve DCE Response Quality
DESCRIPTION:📅 Add to Calendar!   |   🎥 Join Webinar on Zoom \nSpeaker:  \nAssoc Prof Alison Pearce leads the Health Economics team at the University of Sydney Daffodil Centre – a partnership with the Cancer Council NSW. She uses patient preference studies to improve cancer care by providing relevant\, reliable information for decision making. \nDr. Amber Salisbury works as a Health Economics Researcher at the University of Manchester. Her current research centres on patient preference studies that aim to support the implementation of cancer screening within the UK. \nJoin Associate Professor Alison Pearce (University of Sydney Daffodil Centre) and Dr Amber Salisbury (University of Manchester) as they share findings from a series of studies involving almost 4\,000 participants across six discrete choice experiments (DCEs). As DCEs become increasingly popular in health research\, concerns remain about participant engagement\, comprehension\, and the growing challenge of bot responses. This webinar will explore practical strategies commonly used to improve response quality—including encouraging messages\, instructional videos\, and hidden bot-detection questions—and examine whether they actually make a difference. Drawing on empirical evidence\, Alison and Amber will discuss what worked\, what didn’t\, and where researchers should focus their efforts to maximize the quality and reliability of DCE data. This session will be of interest to health economists\, preference researchers\, implementation scientists\, and anyone designing or analyzing DCEs.
URL:https://healtheconomics.org/event/designing-for-decisions-practical-strategies-to-improve-dce-response-quality/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260910T160000
DTEND;TZID=UTC:20260910T170000
DTSTAMP:20260609T053051
CREATED:20260603T171102Z
LAST-MODIFIED:20260603T171113Z
UID:335277-1789056000-1789059600@healtheconomics.org
SUMMARY:Evidence Needs for Evaluating the Cost-Effectiveness of Adult Population Genomic Screening
DESCRIPTION:📅Add to Calendar!  |   🎥 Join Webinar on Zoom \nA key promise of public health genomics is that knowledge of prevalent highly penetrant genotypes for which preventive interventions are readily available\, e.g.\, BRCA1/BRCA2 variants and Lynch syndrome\, can lead to important population health gains. However\, the fulfillment of that promise has been seriously constrained by low numbers of individuals being identified with those genotypes through risk factor-based testing. With the reduction in the cost of genomic sequencing initiatives have increasingly sought to offer sequencing to adults in high-income countries. Cost-effectiveness analyses (CEAs) have concluded that such testing is likely to be cost-effective by usual criteria. However\, the strength of evidence is low. Researchers have assessed hypothetical testing strategies and made assumptions about the uptake of testing and of preventive measures conditional on the knowledge of genomic risks. Demonstration of value for money will require accurate estimates of programmatic implementation costs\, real-world uptake of sequencing\, the frequency and timing of prophylactic practices among individuals identified through population screening initiatives\, and the effectiveness of preventive practices. The presentation will discuss several published CEAs and focus on influential explicit and implicit parameters for which empirical evidence is still needed. \nSpeaker: \nDr Scott Grosse is a health economics and outcomes researcher. \nAfter doctoral studies in public health and economics at the University of Michigan\, he joined the CDC in 1996 and retired at the end of 2024. He has co-authored roughly 300 journal articles\, many of which addressed outcomes and costs associated with newborn screening conditions and the impact of early detection. For more than a decade he was part of the Evidence-based Review Group that conducted evidence syntheses for conditions nominated for the US Recommended Uniform Screening Panel for newborn screening. In addition to his own research\, he collaborated with CDC’s Office of Public Health Genomics and Muin Khoury on seminal papers on the clinical and diagnostic utility and assessments of testing for hereditary disorders in adults. He is a member of the International Health Economics Association\, ISPOR\, the International Society for Neonatal Screening and the International Consortium on Newborn Sequencing.
URL:https://healtheconomics.org/event/evidence-needs-for-evaluating-the-cost-effectiveness-of-adult-population-genomic-screening/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260916T180000
DTEND;TZID=UTC:20260916T190000
DTSTAMP:20260609T053051
CREATED:20260526T174522Z
LAST-MODIFIED:20260526T182546Z
UID:335240-1789581600-1789585200@healtheconomics.org
SUMMARY:Anti-Racist Health Workforce Research and Policy Framework
DESCRIPTION:📅Add to Calendar!    |   🎥 Join Webinar on Zoom \nTaylor Rogers\, PhD\, will present on “Anti-Racist Health Workforce Research and Policy Framework”.  \nSpeaker: \nTaylor Rogers is a Assistant Professor of Health Policy and Management at the University of Hawaii Manoa Thompson School of Social Work and Public Health. Her research uses mixed methods to examine how structural racism shapes entry into and advancement within the population health workforce. She focuses on workforce development and retention among systematically underrepresented communities and investigates how workplace and educational inequities influence career trajectories\, policies\, and population health outcomes. \nAs a full spectrum birth and postpartum doula\, Dr. Rogers brings a practice-based perspective to her scholarship. Supporting Black families through pregnancy\, birth\, and postpartum has given her a grounded understanding of how inequities affect patients and providers alike. This practice informs her academic work and strengthens her commitment to advancing workforce strategies that are equity-driven\, culturally responsive\, community-centered\, and rooted in tradition. \nPrior to joining UH Mānoa\, Dr. Rogers was a Postdoctoral Scholar at the Healthforce Center and the Philip R. Lee Institute for Health Policy Studies at the University of California\, San Francisco.
URL:https://healtheconomics.org/event/anti-racist-health-workforce-research-and-policy-framework/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260923
DTEND;VALUE=DATE:20260925
DTSTAMP:20260609T053051
CREATED:20260512T135701Z
LAST-MODIFIED:20260512T144657Z
UID:335157-1790121600-1790294399@healtheconomics.org
SUMMARY:Croatian Health Economics Workshop (CHEW)
DESCRIPTION:The Croatian Health Economics Association is happy to announce that the 4th Croatian Health Economics Workshop (CHEW) will be held in Rovinj on 23-24 September 2026. \nThe call for abstracts is now OPEN\, with submissions welcome until the 17th May 2026. Feel free to circulate the call forward to potentially interested colleagues. \nWe look forward to receiving your submissions and seeing you in Rovinj! \nOrganising committee: Prof. Ana Bobinac\, Igor Francetić\, Ismar Velić
URL:https://healtheconomics.org/event/croatian-health-economics-workshop-chew/
LOCATION:Hotel Lone\, Rovinj\, Croatia\, Ul. Luje Adamovića 31\, 52210\, Rovinj\, Croatia\, Croatia (Local Name: Hrvatska)
CATEGORIES:External Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260923T110000
DTEND;TZID=UTC:20260923T121500
DTSTAMP:20260609T053051
CREATED:20260507T202740Z
LAST-MODIFIED:20260608T144456Z
UID:335151-1790161200-1790165700@healtheconomics.org
SUMMARY:Health Inequality Aversion in Asia - Early Findings\, Methodological Challenges and Next Steps
DESCRIPTION:📅 Add to Calendar! |  🎥 Join Webinar on Zoom \nBackground: \nEquity in health has been a concern for long and has been central to aspirations for Universal Health Coverage (UHC)\, an objective enshrined in the Sustainable Development Goals (SDGs). Health Technology Assessment (HTA) has been identified as an approach to support UHC by use of evidence to inform policy on allocation of resources for health\, taking equity and other relevant considerations into account. Equity has featured in health economic research using various methodological approaches and over the past decade\, there have been innovations in methodological approaches to address equity through health economic evaluations\, such as Distributional Cost-effectiveness Analysis (DCEA) and Extended Cost-effectiveness Analysis (ECEA). \nThe Equity Informative Economic Evaluation Special Interest Group (SIG) of the the International Health Economics Association (iHEA) seeks to provide a platform for researchers and “encourage the development and synthesis of methods for using economic evaluation to address equity concerns”. More information is available at the following link: https://healtheconomics.org/sigs/eee/ \nTo further this mandate\, the EIEE SIG proposes hosting a series of webinars spanning the next two years. \nObjectives of the series: \n· To learn and share about equity informative health economic evaluations \n· To connect researchers working on equity informative health economic evaluations and form partnerships \n· To identify potential areas for future research and collaboration on equity informative health economic evaluations \n  \nThe first of the webinar series is: Health Inequality Aversion in Asia – Early Findings\, Methodological Challenges and Next Steps\, with the aim to: \n· To share findings from studies conducted on inequity \n· To learn about methodological challenges and potential applications \n· To identify potential areas for collaboration \nSpeakers: \n \nDr. Xiaoning He is an Associate Professor and Doctoral Supervisor at the School of Pharmaceutical Science and Technology\, Tianjin University.  \nShe was a visiting scholar at the University of Sheffield\, UK\, from September 2019 to March 2020. Her research interests cover pharmacoeconomics\, real-world evidence studies\, and health policy evaluation. She has served as the Principal Investigator (PI) for the General Program and Youth Program of the National Natural Science Foundation of China\, as well as for the General Program and Youth Program of the Tianjin Natural Science Foundation. Additionally\, she acts as a sub-project leader for the Major Program of the National Social Science Fund of China. She has authored more than 70 peer-reviewed journal articles\, among which over 40 are indexed in SCI/SSCI\, published in reputable journals including Value in Health and Pharmacoeconomics. She also contributed to the compilation of the China Guidelines for Pharmacoeconomic Evaluation 2025. She serves as Member and Secretary of the Pharmacoeconomics Committee of the Chinese Pharmaceutical Association\, Standing Committee Member of the Pharmacoeconomics Committee of the China Health Insurance Research Association\, and Member and Secretary of the Pharmacoeconomics Committee of the Tianjin Pharmaceutical Association. \n \nDr. Sitanshu Sekhar Kar is a Professor in the Department of Preventive and Social Medicine\, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)\, Puducherry.  \nHis areas of interest are Epidemiology\, NCD prevention & Health Promotion\, Health System Strengthening\, and Medical Education. He is leading the distributional cost-effective analysis study in India. He is passionate about capacity strengthening of early career researchers and led the inaugural programme through HTAsiaLink. He has contributed to the research community and was the Chief Editor of the International Journal of Medicine and Public Health (2013-2015)\, and a member of the Editorial Board of the Indian Journal of Community & Family Medicine and NTTC Bulletin. He is a reviewer of many national and international peer-reviewed journals like BMC Health\, Health Promotion International\, International Journal of Medicine and Public Health\, Indian Journal of Community Health\, IJOEM\, IJMS\, Journal of Pharmacology and Therapeutics & Indian Journal of Public Health. \n \nDr. Wanrudee Isaranuwatchai\, Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP)\, Thailand and Affiliated Scientist at St. Michael’s Hospital\, and an Associate Professor at the Institute of Health Policy\, Management and Evaluation\, University of Toronto\, in Canada. \nHer research focuses on how to apply health economics and health technology assessment (HTA) in the real-world setting as well as how to advance methods in economic evaluation (EE). She has experience conducting EEs using various methods with specific interest in the potential of big data in health economics and HTA to support evidence generation and policy-making process. \nShe has also collaborated with researchers\, health professionals\, and policy-makers in various areas to help communicate the value of health initiatives using EE. She has contributed to the training on HTA to support health systems in Asia\, Africa\, and North America. Dr. Isaranuwatchai is dedicated to the creation and use of evidence in healthcare decision making. \n \nDr. Stéphane Verguet is an Associate Professor of Global Health in the Department of Global Health and Population at the Harvard T.H. Chan School of Public Health and a core faculty member of Harvard University’s Center for Health Decision Science.  \nHis research concerns health systems\, health economics\, and priority setting\, with significant contributions toward incorporating dimensions of equity into the economic evaluation of health policies and priority setting through the modeling of health benefit packages and intersectoral interventions\, via applied economic evaluations. He has co-chaired the Analytics & Metrics Community of Practice of the Research Consortium for School Health & Nutrition since 2021 and has contributed to the World Bank’s Disease Control Priorities since 2009\, most recently as a lead editor for the Universal Health Coverage volume of its fourth edition. He was also a Commissioner of The Lancet Global Health 2050 Commission. Verguet has degrees from the University of California\, Berkeley\, and the École Polytechnique and was previously on the faculty of the University of Washington. \n \nDr. Richard Cookson is a Professor at the Centre for Health Economics\, and Co-Director of the Equity in Health Policy (Equipol) research group. \nHe has helped pioneer “equity-informative” methods of policy analysis\, including distributional cost-effectiveness analysis; health equity indicators for healthcare quality assurance; and methods for investigating public concern for reducing health inequality; and is currently developing microsimulation methods for long-term childhood policy analysis.  He has co-chaired international working groups on equity\, worked in the UK Prime Minister’s Delivery Unit and served on various NHS advisory committees including the National Institute for Health and Care Excellence and the NHS Advisory Committee on Resource Allocation. Richard’s research focuses on equity in health and health care. Richard is an Honorary Public Health Academic\, Office for Health Improvement and Disparities. He has co-chaired various international working groups on equity; served on various NHS advisory groups including the National Institute for Health and Clinical Excellence (NICE) Technology Appraisal Committee 2002-7\, the Public Health Interventions Advisory Committee 2007-9\, the NHS Outcomes Framework Technical Advisory Committee 2012-16 and the NHS Advisory Committee for Resource Allocation 2017-21; and was seconded to the Prime Minister’s Delivery Unit in the Treasury in 2010. Richard holds a BA in Politics\, Philosophy and Economics and a DPhil in Economics from the University of York\, and an MPhil in Economics from the University of Oxford. \nResources\n\nHealth technology assessment – Global\nSelected\n\n\n\n\n\n\nWHO resolution 67.23 – Health intervention and technology assessment in support of universal health coverage\nSEA/RC66/R4 – Health intervention and technology assessment in support of universal health coverage\n\n\n\n\n\n\nO’Rourke B\, Oortwijn W\, Schuller T. The new definition of health technology assessment: A milestone in international collaboration. International journal of technology assessment in health care. 2020 Jun;36(3):187-90.\nDistributional cost-effectiveness analysis (DCEA) – Centre for Health Economics\, University of York\nTutorial: Extended Cost-Effectiveness Analysis
URL:https://healtheconomics.org/event/health-inequality-aversion-in-asia-early-findings-methodological-challenges-and-next-steps/
LOCATION:Zoom
CATEGORIES:IHEA Event
END:VEVENT
END:VCALENDAR